Have a personal or library account? Click to login
Significance of Serum Uric Acid in Children with Pulmonary Arterial Hypertension Cover

Significance of Serum Uric Acid in Children with Pulmonary Arterial Hypertension

Open Access
|Jul 2016

References

  1. 1. Pezzuto B, Badagliacca R, Poscia R, et al. Circulating biomarkers in pulmonary arterial hypertension: Update and future direction. J Heart Lung Transplant. 2015;34:282-305.10.1016/j.healun.2014.12.00525682555
  2. 2. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003;107:1991-1997.10.1161/01.CIR.0000065637.10517.A012707250
  3. 3. Shimizu Y, Nagaya N, Satoh T, et al. Serum acid uric level increases in proportion to the severity of pulmonary thromboembolism. Circ J. 2002;66:571-575.10.1253/circj.66.57112074276
  4. 4. Nagaya N, Uematsu M, Satoh T, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med. 1999;160:487-492.10.1164/ajrccm.160.2.981207810430718
  5. 5. Oya H, Nagaya N, Satoh T, et al. Haynamic correlates and pronostic significance of uric acid in adults patients with Eisenmenger syndrome. Heart. 2000;84:53-58.10.1136/heart.84.1.53172941010862589
  6. 6. Dimitroulas T, Giannakoulas G, Dimitroula H, et al. Significance of serum uric acid in pulmonary hypertension dueto systemic slerosis: a pilot study. Rheumatol Int. 2011;31:263-267.10.1007/s00296-010-1557-420658290
  7. 7. Zang CY, Ma LL, Wang CX. Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension. Exp Clin Cardiol. 2013;18(1):37-39.
  8. 8. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelium dysfunction. Kidney Int. 2005;67:1739-1742.10.1111/j.1523-1755.2005.00273.x15840020
  9. 9. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37(1):67-11910.1093/eurheartj/ehv31726320113
  10. 10. Suteu C, Blesneac C, Toganel R, et al. Epidemiological characteristics and prospective follow-up of children with pulmonary arterial hypertension. Acta Medica Marisiensis. 2015;61(2):75-82.10.1515/amma-2015-0026
  11. 11. Opotowsky AR, Clair M, Afilalo J. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013;112:873-882.10.1016/j.amjcard.2013.05.016431736023735649
  12. 12. Bendayan D, Shitrit D, Ygla M, et al. Hyperuricemia as a pronostic factor in pulmonary arterial hypertension. Respir Med. 2003;97:130-133.10.1053/rmed.2003.1440
  13. 13. Van Albada ME, Loot FG, Fokkema R, et al. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatric Research. 2008;63(3):321-327.10.1203/PDR.0b013e318163a2e7
  14. 14. Voelkel MA, Wynne KM, Badesch DB, et al. Hyperuricemia in severe pulmonary hypertension. Chest. 2000;117:19-24.10.1378/chest.117.1.19
  15. 15. Bossome E, Bodini BD, Mazza A, et al. Pulmonary arterial hypertension, the key role of echocardiography. Chest. 2005;127:1836-1843.10.1378/chest.127.5.1836
  16. 16. Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:1380-1386.10.1016/S0735-1097(03)00121-9
  17. 17. Colvin KL, Dufva MJ, Delaney RP, et al. Biomarkers for pediatric pulmonary arterial hypertension- a call to collaborate. Frontiers in Pediatrics. 2014;2(7):1-12.10.3389/fped.2014.00007
  18. 18. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214-1219.10.1016/S0735-1097(02)01744-8
  19. 19. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension. Circulation. 1989;80:353-360.10.1161/01.CIR.80.2.3532752562
  20. 20. Vonk MC, Sander MH, van der Hoogen, et al. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue disease. Eur J Echocardiogr. 2007;8:317-321.10.1016/j.euje.2006.06.00216846757
  21. 21. Anavekar NS, Gerson D, Skali H, et al. Two- dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography. 2007;24(5):452-456.10.1111/j.1540-8175.2007.00424.x17456062
  22. 22. Jone PN, Ivy DD. Echocardiography in pediatric pulmonary hypertension. Frontiers in paediatrics. 2014;124(2).10.3389/fped.2014.00124422885025429362
DOI: https://doi.org/10.1515/jim-2016-0010 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 46 - 50
Submitted on: Mar 31, 2016
Accepted on: May 14, 2016
Published on: Jul 6, 2016
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Carmen Corina Şuteu, Theodora Benedek, Rodica Togănel, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.